Naoki Wada1,2, Takahiro Shimizu1, Nobutaka Shimizu1, William C de Groat3, Anthony J Kanai4, Pradeep Tyagi1, Hidehiro Kakizaki2, Naoki Yoshimura1,3. 1. Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 2. Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Japan. 3. Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 4. Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Abstract
AIMS: To investigate the role of nerve growth factor (NGF) in lower urinary tract dysfunction in mice with spinal cord injury (SCI). METHODS: Using 4-week SCI mice, single-filling cystometry and external urethral sphincter (EUS)-electromyography were performed under an awake condition. In some SCI mice, anti-NGF antibodies (10 µg/kg/h) were administered for 1 or 2 weeks before the urodynamic study. NGF levels in the bladder and L6/S1 spinal cord were assayed by ELISA. The transcript levels of P2X receptors and TRP channels in L6/S1 dorsal root ganglia (DRG) were measured by RT-PCR. RESULTS: In SCI mice, the area under the curve of non-voiding contractions (NVCs) during the storage phase was significantly decreased in both 1- and 2-week anti-NGF antibody-treated SCI groups. However, EUS-electromyogram parameters during voiding were not altered by the treatment. Bladder mucosal and spinal NGF levels were decreased after 2 weeks of anti-NGF antibody treatment. TRPA1 and TRPV1 transcripts in L6/S1 DRG were significantly decreased after 1- or 2-week anti-NGF treatment. CONCLUSIONS: In SCI mice, NGF is involved in the emergence of NVCs in association with increased expression of TRP receptors that are predominantly found in C-fiber afferent pathways. Thus, NGF targeting treatments could be effective for treating storage problems such as detrusor overactivity after SCI.
AIMS: To investigate the role of nerve growth factor (NGF) in lower urinary tract dysfunction in mice with spinal cord injury (SCI). METHODS: Using 4-week SCI mice, single-filling cystometry and external urethral sphincter (EUS)-electromyography were performed under an awake condition. In some SCI mice, anti-NGF antibodies (10 µg/kg/h) were administered for 1 or 2 weeks before the urodynamic study. NGF levels in the bladder and L6/S1 spinal cord were assayed by ELISA. The transcript levels of P2X receptors and TRP channels in L6/S1 dorsal root ganglia (DRG) were measured by RT-PCR. RESULTS: In SCI mice, the area under the curve of non-voiding contractions (NVCs) during the storage phase was significantly decreased in both 1- and 2-week anti-NGF antibody-treated SCI groups. However, EUS-electromyogram parameters during voiding were not altered by the treatment. Bladder mucosal and spinal NGF levels were decreased after 2 weeks of anti-NGF antibody treatment. TRPA1 and TRPV1 transcripts in L6/S1 DRG were significantly decreased after 1- or 2-week anti-NGF treatment. CONCLUSIONS: In SCI mice, NGF is involved in the emergence of NVCs in association with increased expression of TRP receptors that are predominantly found in C-fiber afferent pathways. Thus, NGF targeting treatments could be effective for treating storage problems such as detrusor overactivity after SCI.
Authors: André Santos-Silva; Ana Charrua; Célia D Cruz; Laxmikant Gharat; António Avelino; Francisco Cruz Journal: Auton Neurosci Date: 2011-10-28 Impact factor: 3.145
Authors: Naoki Yoshimura; Nelson E Bennett; Yukio Hayashi; Teruyuki Ogawa; Osamu Nishizawa; Michael B Chancellor; William C de Groat; Satoshi Seki Journal: J Neurosci Date: 2006-10-18 Impact factor: 6.167
Authors: T Yoshizawa; K Kadekawa; P Tyagi; S Yoshikawa; R Takahashi; S Takahashi; N Yoshimura Journal: Spinal Cord Date: 2014-12-23 Impact factor: 2.772
Authors: Satoshi Seki; Katsumi Sasaki; Matthew O Fraser; Yasuhiko Igawa; Osamu Nishizawa; Michael B Chancellor; William C de Groat; Naoki Yoshimura Journal: J Urol Date: 2002-11 Impact factor: 7.450
Authors: Sílvia Sousa Chambel; Ana Ferreira; Raquel Oliveira; Rafael Miranda; Luís Vale; Carlos Reguenga; Martin E Schwab; Célia Duarte Cruz Journal: Int J Mol Sci Date: 2022-08-04 Impact factor: 6.208